A Pilot Study of Repeated Dose Intrapleural Adenoviral-Mediated Interferon-Alpha (SCH 721015, Ad.hIFN-a2b) Gene Transfer for Malignant Pleural Mesothelioma
Phase of Trial: Phase I
Latest Information Update: 24 Sep 2015
At a glance
- Drugs Nadofaragene-firadenovec (Primary)
- Indications Mesothelioma
- Focus Pharmacogenomic; Pharmacokinetics
- 27 Jul 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Apr 2015 Status changed from recruiting to active, no longer recruiting, according to to ClinicalTrials.gov record.
- 07 Oct 2010 New trial record